Clinical Trials Consumption THC Therapy 
NORML
FEBRUARY 25, 2020
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
CannaMD
AUGUST 26, 2020
A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
DECEMBER 28, 2023
THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis. Strains with a balanced THC and CBD ratio are often recommended for their synergistic effects in pain relief without the intense psychoactive experience.
MMJ Recs
APRIL 1, 2024
Unlike its counterpart THC (tetrahydrocannabinol), CBD doesn’t produce psychoactive effects, making it an attractive option for those seeking therapeutic relief without the “high” associated with traditional marijuana use.
CannaMD
MAY 12, 2021
It’s well known that marijuana can be an agent for appetite stimulation, making it a valuable therapy for mitigating the weight loss sometimes associated with conditions such as HIV/AIDS and cancer. It therefore stands to reason that therapies addressing anxiety and OCD might have a positive effect on eating disorders.
The Cannigma
FEBRUARY 2, 2021
However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. million clinical trial investigating the effects of CBD on hallucinations and delusions related to the disease.
Project CBD
AUGUST 6, 2019
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Twenty percent of the samples contained less CBD than indicated on the label.
Expert insights. Personalized for you.
228 
Let's personalize your content